Krempa David bought ETON
December 11, 2025 · Form 4 insider transaction
Krempa David bought 5,300 shares of Eton Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,300
Price
$0.00
Total value
N/A
InsiderKrempa David
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateDecember 12, 2025
Shares owned after638,468
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.; The restricted stock units vest immediately as of the award date.